ARTICLE | Politics, Policy & Law
Industry avoids tariff bullet, for now
By Steve Usdin, Washington Editor
April 4, 2025 1:22 AM UTC
Biopharmaceutical companies may have dodged the worst of President Donald Trump’s tariffs for now, but industry lobbyists are expecting the Trump administration to launch an investigation that could lead to the imposition of pharmaceutical-specific tariffs in the coming months.
President Trump exempted pharmaceuticals from Wednesday’s “reciprocal” tariffs, which start at a base rate of 10% and vary by country based on trade balances with the U.S…
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: https://www.biocentury.com/article/655524/pharma-industry-may-yet-face-trump-tariffs
